242 related articles for article (PubMed ID: 26412386)
1. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
Song S; Wang Y; Xu P; Yang R; Ma Z; Liang S; Zhang G
Int J Oncol; 2015 Nov; 47(5):1819-28. PubMed ID: 26412386
[TBL] [Abstract][Full Text] [Related]
2. The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.
Wu J; Du C; Lv Z; Ding C; Cheng J; Xie H; Zhou L; Zheng S
Dig Dis Sci; 2013 Dec; 58(12):3545-53. PubMed ID: 24077923
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
4. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
5. HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST).
Lopez G; Bill KL; Bid HK; Braggio D; Constantino D; Prudner B; Zewdu A; Batte K; Lev D; Pollock RE
PLoS One; 2015; 10(7):e0133302. PubMed ID: 26200462
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 8 in neuroblastoma tumorigenesis.
Oehme I; Deubzer HE; Wegener D; Pickert D; Linke JP; Hero B; Kopp-Schneider A; Westermann F; Ulrich SM; von Deimling A; Fischer M; Witt O
Clin Cancer Res; 2009 Jan; 15(1):91-9. PubMed ID: 19118036
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma.
Ahn MY; Yoon JH
Oncol Rep; 2017 Jan; 37(1):540-546. PubMed ID: 28004115
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL
Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163
[TBL] [Abstract][Full Text] [Related]
9. Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer.
Xiong K; Zhang H; Du Y; Tian J; Ding S
Exp Mol Med; 2019 Aug; 51(8):1-15. PubMed ID: 31451695
[TBL] [Abstract][Full Text] [Related]
10. Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823.
Fan L; Tan B; Li Y; Zhao Q; Liu Y; Wang D; Zhang Z
Int J Clin Exp Pathol; 2015; 8(10):12428-36. PubMed ID: 26722429
[TBL] [Abstract][Full Text] [Related]
11. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
Wang Y; Xu P; Yao J; Yang R; Shi Z; Zhu X; Feng X; Gao S
Target Oncol; 2016 Apr; 11(2):197-207. PubMed ID: 26408293
[TBL] [Abstract][Full Text] [Related]
13. HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.
Dasgupta T; Antony J; Braithwaite AW; Horsfield JA
J Biol Chem; 2016 Jun; 291(24):12761-12770. PubMed ID: 27072133
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression.
Xu G; Li N; Zhang Y; Zhang J; Xu R; Wu Y
Braz J Med Biol Res; 2019; 52(8):e8341. PubMed ID: 31365693
[TBL] [Abstract][Full Text] [Related]
15. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression.
Kang ZH; Wang CY; Zhang WL; Zhang JT; Yuan CH; Zhao PW; Lin YY; Hong S; Li CY; Wang L
PLoS One; 2014; 9(6):e98894. PubMed ID: 24896240
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
18. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
19. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
Ramos TL; Sánchez-Abarca LI; Redondo A; Hernández-Hernández Á; Almeida AM; Puig N; Rodríguez C; Ortega R; Preciado S; Rico A; Muntión S; Porras JRG; Del Cañizo C; Sánchez-Guijo F
Oncotarget; 2017 Apr; 8(17):28187-28202. PubMed ID: 28390197
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.
Xu G; Zhu H; Zhang M; Xu J
Int J Mol Med; 2018 Jan; 41(1):155-163. PubMed ID: 29115379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]